Member Info for DanRey

Been no action for weeks other than a slow decline in price. Phase 1 completed then standstill. Hope lots going on behind the scenes.

Always the same how a couple of hundred thousand share sells cause a fall in the price yet a six hundred thousand buy doesn’t take it back up. The markets always seem to react so quick to selling pressure compared to buying or so it seems.

Just getting over covid and have had some what appeared to be trigemenal pain which can be a viral symptom. Was awful and not touched by available analgesics. Having read more about trigemenal Neuralgia and the limited available treatment for this miserable condition hopefully if successful our medication can’t come soon enough.

Good news.

Only 6 trading days left in Q3.

Am hopeful when you can dummy sell your holding but can't buy back the same amount things maybe looking up.

Before the AGM hopefully

Mr India. The negativity towards the stock is because Hemo so far failed to deliver and confidence was broken. To fall at the last hurdle when it was believed that Hemo had been involved with the FDA to process approval seems poor and thus collapse in confidence. It felt like another Mint moment. It seems that this is the price range while people wait and see if progress is made. I like many have been burned by false dawns and want to see some solid results before committing again.

Oh well. Was hoping yesterday there was some buying however that large sell seems to have put an end to that.

Some reasonable buys today. Hoping for good result from phase 1. Not to long to wait now.

Soon entering the last month of Q3. Not long to wait for results from Phase 1 trial.

Would be nice to push up to year highs of 1.50 next week as we get nearer to results and news of phase 1 trials.

I would have thought the share price will be news and result driven hopefully moving into phase 2.

Negotiated to buy. Hopefully rerate on way.

I hope so.

They are all tiny trades.

There are so many people that current analgesics don’t work for. Morphine based looses its effects over time, Anti inflammatory are contraindicated in so many illnesses and the use of antidepressants/anti epileptic for nerve pain is sometimes questioned so there is definitely need for alternatives.

Hope we hear later today some news as to where we are in the trials and give us some pointers to reignite some interest moving forward.

Sadly still would appear predominantly sells. I thought we would settle in the 1.3 -1.5 range while in early trials and move up during next phase. Not that confidence it would seem.

Thought it would not be too difficult to get participants signed up for this phase 1 trial. Cannabis has been used for thousands of years and risks/side effects I would hope are much less than with the vast majority of other trial drugs.